CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L107. A total of 2 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $4,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bracebridge Capital, LLC | 2,002,495 | $761,000 | 0.12% |
SABBY MANAGEMENT, LLC | 200,000 | $76,000 | 0.05% |
Ayrton Capital LLC | 32,525 | $12,000 | 0.02% |
Powell Investment Advisors, LLC | 60,000 | $23,000 | 0.01% |
Virtu Financial LLC | 188,086 | $72,000 | 0.01% |
Warberg Asset Management LLC | 55,000 | $21,000 | 0.01% |
UBS Group AG | 23,534 | $9,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 45,000 | $17,000 | 0.00% |
Squarepoint Ops LLC | 29,085 | $11,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 10,001 | $4,000 | 0.00% |